CoChat
Sign Up
Cited by 113Multiple Sclerosis Research StudiesProtease and Inhibitor MechanismsBarrier Structure and Function Studies

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier

Gerwien, Hanna, Hermann, Sven, Zhang, Xueli, Korpos, Eva, Song, Jian, Kopka, Klaus, Faust, Andreas, Wenning, Christian, Gross, Catharina C., Honold, Lisa, Melzer, Nico, Opdenakker, Ghislain, Wiendl, Heinz, Schäfers, Michael, Sorokin, Lydia·2016·Science Translational Medicine
DOI 10.1126/scitranslmed.aaf8020
Open this paper in CoChat — free account

Abstract

The enzymes gelatinase A/matrix metalloproteinase-2 (MMP-2) and gelatinase B/MMP-9 are essential for induction of neuroinflammatory symptoms in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS); in the absence of these enzymes, the disease does not develop. We therefore investigated the cellular sources and relative contributions of MMP-2 and MMP-9 to disease at early stages of EAE induction. We demonstrated that MMP-9 from an immune cell source is required in EAE for initial infiltration of leukocytes into the central nervous system and that MMP-9 activity is a reliable marker of leukocyte penetration of the blood-brain barrier. We then developed a molecular imaging method to visualize MMP activity in the brain using fluorescent- and radioactive-labeled MMP inhibitors (MMPis) in EAE animals and used the radioactive MMP ligand for positron emission tomography (PET) imaging of MMP activity in patients with MS. In contrast to traditional T1-gadolinium contrast-enhanced MRI, MMPi-PET enabled tracking of MMP activity as a unique feature of early lesions and ongoing leukocyte infiltration. MMPi-PET therefore allows monitoring of the early steps of MS development and provides a sensitive, noninvasive means of following lesion formation and resolution in murine EAE and human MS.

Overview

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaf8020

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Gijbels K., Steinman L., Gelatinase B producing cells in multiple sclerosis lesions. J. Cell. Biochem. Suppl. 18D, 143 (1994).

Cited by

Sorted by citations

See all 113

Related

See all

Metadata

Authors
Gerwien, H., Hermann, S., Zhang, X., Korpos, E., Song, J., Kopka, K., Faust, A., Wenning, C., Gross, C. C., Honold, L., Melzer, N., Opdenakker, G., Wiendl, H., Schäfers, M., & Sorokin, L.
Affiliations
  • University of Münster (DE)
  • Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, DE-48149 Münster, Germany.
  • Rega Institute for Medical Research (BE)
Corresponding author
  • Gerwien, Hanna
  • Hermann, Sven
  • Kopka, Klaus
  • Schäfers, Michael
  • Sorokin, Lydia
ORCID
Venue
Science Translational Medicine
Publisher
American Association for the Advancement of Science (AAAS)
Published
2016-11-09
Volume
8
Issue
364
Pages
364ra152-364ra152
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
DOI
10.1126/scitranslmed.aaf8020
OpenAlex
W2553357145
Cited by
113
References
45
Citations by year
2026: 7 · 2025: 7 · 2024: 11 · 2023: 10 · 2022: 11 · 2021: 10 · 2020: 11 · 2019: 8 · 2018: 29 · 2017: 8 · 2016: 1
FWCI
13.94
Type
journal article
Language
en
Open access
closed
Licence
www.sciencemag.org/about/science-licenses-journal-article-reuse (vor, 365 d)
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion)
Funders
  • German Research Foundation
  • Geconcerteerde Onderzoeksacties (GOA 2013/15)
  • Charcot Foundation
  • Fund for Scientific Research of Flanders
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
multiple sclerosis, MMP-9, MMP-2, experimental autoimmune encephalomyelitis, blood-brain barrier, leukocyte infiltration, matrix metalloproteinase inhibitors, positron emission tomography, molecular imaging, neuroinflammation, disease surveillance
MeSH terms
Animals, Blood-Brain Barrier, Brain, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immune System, Inflammation, Leukocytes, Ligands, Magnetic Resonance Imaging, Male, Mice, Inbred C57BL, Mice, Transgenic, Multiple Sclerosis, Spinal Cord, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Matrix Metalloproteinases, Positron-Emission Tomography, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review